| References |
|
|
Aldinucci D,
Lorenzon D,
Cattaruzza L et al.
(2008)
Expression of CCR5 receptors on Reed-Sternberg cells and Hodgkin lymphoma cell lines: involvement of CCL5/Rantes in tumor cell growth and microenvironmental interactions.
International Journal of Cancer
122:
769–776.
|
|
|
Alfonso-Perez M,
Lopez-Giral S,
Quintana NE et al.
(2006)
Anti-CCR7 monoclonal antibodies as a novel tool for the treatment of chronic lymphocyte leukemia.
Journal of Leukocyte Biology
79:
1157–1165.
|
|
|
Alsayed Y,
Ngo H,
Runnels J et al.
(2007)
Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma.
Blood
109:
2708–2717.
|
|
|
Arendt BK,
Velazquez-Dones A,
Tschumper RC et al.
(2002)
Interleukin 6 induces monocyte chemoattractant protein-1 expression in myeloma cells.
Leukemia
16:
2142–2147.
|
|
|
Barone F,
Bombardieri M,
Rosado MM et al.
(2008)
CXCL13, CCL21, and CXCL12 expression in salivary glands of patients with Sjogren's syndrome and MALT lymphoma: association with reactive and malignant areas of lymphoid organization.
Journal of Immunology
180:
5130–5140.
|
|
|
Basso K,
Liso A,
Tiacci E et al.
(2004)
Gene expression profiling of hairy cell leukemia reveals a phenotype related to memory B cells with altered expression of chemokine and adhesion receptors.
Journal of Experimental Medicine
199:
59–68.
|
|
|
Bradstock KF,
Makrynikola V,
Bianchi A et al.
(2000)
Effects of the chemokine stromal cell-derived factor-1 on the migration and localization of precursor-B acute lymphoblastic leukemia cells within bone marrow stromal layers.
Leukemia
14:
882–888.
|
|
|
Buonamici S,
Trimarchi T,
Ruocco MG et al.
(2009)
CCR7 signalling as an essential regulator of CNS infiltration in T-cell leukaemia.
Nature
459:
1000–1004.
|
|
|
Burger JA,
Burger M and
Kipps TJ
(1999)
Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells.
Blood
94:
3658–3667.
|
|
|
Burger JA,
Quiroga MP,
Hartmann E et al.
(2009)
High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation.
Blood
113:
3050–3058.
|
|
|
Choi SJ,
Cruz JC,
Craig F et al.
(2000)
Macrophage inflammatory protein 1-alpha is a potential osteoclast stimulatory factor in multiple myeloma.
Blood
96:
671–675.
|
|
|
Choi SJ,
Oba Y,
Gazitt Y et al.
(2001)
Antisense inhibition of macrophage inflammatory protein 1-alpha blocks bone destruction in a model of myeloma bone disease.
Journal of Clinical Investigation
108:
1833–1841.
|
|
|
Corcione A,
Arduino N,
Ferretti E et al.
(2004)
CCL19 and CXCL12 trigger in vitro chemotaxis of human mantle cell lymphoma B cells.
Clinical Cancer Research
10:
964–971.
|
|
|
Corcione A,
Arduino N,
Ferretti E et al.
(2006)
Chemokine receptor expression and function in childhood acute lymphoblastic leukemia of B-lineage.
Leukemia Research
30:
365–372.
|
|
|
Corcione A,
Ottonello L,
Tortolina G et al.
(2000)
Stromal cell-derived factor-1 as a chemoattractant for follicular center lymphoma B cells.
Journal of the National Cancer Institute
92:
628–635.
|
|
|
Fedyk ER,
Ryyan DH,
Ritterman I and
Springer TA
(1999)
Maturation decreases responsiveness of human bone marrow B lineage cells to stromal-derived factor 1 (SDF-1).
Journal of Leukocyte Biology
66:
667–673.
|
|
|
Fischer M,
Juremalm M,
Olsson N et al.
(2003)
Expression of CCL5/RANTES by Hodgkin and Reed-Sternberg cells and its possible role in the recruitment of mast cells into lymphomatous tissue.
International Journal of Cancer
107:
197–201.
|
|
|
Fujii A,
Ohshima K,
Hamasaki M et al.
(2004)
Differential expression of chemokines, chemokine receptors, cytokines and cytokine receptors in diffuse large B cell malignant lymphoma.
International Journal of Oncology
24:
529–538.
|
|
|
Fujita Y,
Abe R,
Sasaki M et al.
(2006)
Presence of circulating CCR10+ T cells and elevated serum CTACK/CCL27 in the early stage of mycosis fungoides.
Clinical Cancer Research
12:
2670–2675.
|
|
|
Ghia P,
Transidico P,
Veiga JP et al.
(2001)
Chemoattractants MDC and TARC are secreted by malignant B-cell precursors following CD40 ligation and support the migration of leukemia-specific T cells.
Blood
98:
533–540.
|
|
|
Giuliani N,
Bonomini S,
Romagnani P et al.
(2006)
CXCR3 and its binding chemokines in myeloma cells: expression of isoforms and potential relationships with myeloma cell proliferation and survival.
Haematologica
91:
1489–1497.
|
|
|
Giuliani N,
Lisignoli G,
Colla S et al.
(2008)
CC-Chemokine ligand 20/macrophage inflammatory protein-3alpha and CC-chemokine receptor 6 are overexpressed in myeloma microenvironment related to osteolytic bone lesions.
Cancer Research
68:
6840–6850.
|
|
|
Hanamoto H,
Nakayama T,
Miyazato H et al.
(2004)
Expression of CCL28 by Reed-Sternberg cells defines a major subtype of classical Hodgkin's disease with frequent infiltration of eosinophils and/or plasma cells.
American Journal of Pathology
164:
997–1006.
|
|
|
Harris NL,
Jaffe ES,
Diebold J et al.
(1999)
World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.
Journal of Clinical Oncology
17:
3835–3849.
|
|
|
Hasegawa H,
Nomura T,
Kohno M et al.
(2000)
Increased chemokine receptor CCR7/EBI1 expression enhances the infiltration of lymphoid organs by adult T-cell leukemia cells.
Blood
95:
30–38.
|
|
|
Hopken UE,
Foss HD,
Meyer D et al.
(2002)
Up-regulation of the chemokine receptor CCR7 in classical but not in lymphocyte-predominant Hodgkin disease correlates with distinct dissemination of neoplastic cells in lymphoid organs.
Blood
99:
1109–1116.
|
|
|
Husson H,
Freedman AS,
Cardoso AA et al.
(2002)
CXCL13 (BCA-1) is produced by follicular lymphoma cells: role in the accumulation of malignant B cells.
British Journal of Haematology
119:
492–495.
|
|
|
Ishida T,
Ishii T,
Inagaki A et al.
(2006)
Specific recruitment of CC chemokine receptor 4-positive regulatory T cells in Hodgkin lymphoma fosters immune privilege.
Cancer Research
66:
5716–5722.
|
|
|
Ishida T,
Utsunomiya A,
Iida S et al.
(2003)
Clinical significance of CCR4 expression in adult T-cell leukemia/lymphoma: its close association with skin involvement and unfavorable outcome.
Clinical Cancer Research
9:
3625–3634.
|
|
|
Jones D,
Benjamin RJ,
Shahsafaei A and
Dorfman DM
(2000)
The chemokine receptor CXCR3 is expressed in a subset of B-cell lymphomas and is a marker of B-cell chronic lymphocytic leukemia.
Blood
95:
627–632.
|
|
|
Juarez J,
Bradstock KF,
Gottlieb DJ and
Bendall LJ
(2003)
Effects of inhibitors of the chemokine receptor CXCR4 on acute lymphoblastic leukemia cells in vitro.
Leukemia
17:
1294–1300.
|
|
|
Juarez J,
Dela Pena A,
Baraz R et al.
(2007)
CXCR4 antagonists mobilize childhood acute lymphoblastic leukemia cells into the peripheral blood and inhibit engraftment.
Leukemia
21:
1249–1257.
|
|
|
Kleinhans M,
Tun-Kyi A,
Gilliet M et al.
(2003)
Functional expression of the eotaxin receptor CCR3 in CD30+ cutaneous T-cell lymphoma.
Blood
101:
1487–1493.
|
|
|
Lentzsch S,
Gries M,
Janz M et al.
(2003)
Macrophage inflammatory protein 1-alpha (MIP-1 alpha ) triggers migration and signaling cascades mediating survival and proliferation in multiple myeloma (MM) cells.
Blood
101:
3568–3573.
|
|
|
Mazzucchelli L,
Blaser A,
Kappeler A et al.
(1999)
BCA-1 is highly expressed in Helicobacter pylori-induced mucosa-associated lymphoid tissue and gastric lymphoma.
Journal of Clinical Investigation
104:
R49–R54.
|
|
|
Mohle R,
Failenschmid C,
Bautz F and
Kanz L
(1999)
Overexpression of the chemokine receptor CXCR4 in B cell chronic lymphocytic leukemia is associated with increased functional response to stromal cell-derived factor-1 (SDF-1).
Leukemia
13:
1954–1959.
|
|
|
Mourad N,
Mounier N,
Briere J et al.
(2008)
Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials.
Blood
111:
4463–4470.
|
|
|
Narducci MG,
Scala E,
Bresin A et al.
(2006)
Skin homing of Sezary cells involves SDF-1-CXCR4 signaling and down-regulation of CD26/dipeptidylpeptidase IV.
Blood
107:
1108–1115.
|
|
|
Pellegrino A,
Ria R,
Di Pietro G et al.
(2005)
Bone marrow endothelial cells in multiple myeloma secrete CXC-chemokines that mediate interactions with plasma cells.
British Journal of Haematology
129:
248–256.
|
|
|
Qiuping Z,
Jie X,
Youxin J et al.
(2005)
Selectively frequent expression of CXCR5 enhances resistance to apoptosis in CD8(+)CD34(+) T cells from patients with T-cell-lineage acute lymphocytic leukemia.
Oncogene
24:
573–584.
|
|
|
Spiegel A,
Kollet O,
Peled A et al.
(2004)
Unique SDF-1-induced activation of human precursor-B ALL cells as a result of altered CXCR4 expression and signaling.
Blood
103:
2900–2907.
|
|
|
Suefuji H,
Ohshima K,
Karube K et al.
(2005)
CXCR3-positive B cells found at elevated frequency in the peripheral blood of patients with MALT lymphoma are attracted by MIG and belong to the lymphoma clone.
International Journal of Cancer
114:
896–901.
|
|
|
Tanaka Y,
Mine S,
Figdor CG et al.
(1998)
Constitutive chemokine production results in activation of leukocyte function-associated antigen-1 on adult T-cell leukemia cells.
Blood
91:
3909–3919.
|
|
|
Teruya-Feldstein J,
Jaffe ES,
Burd PR et al.
(1999)
Differential chemokine expression in tissues involved by Hodgkin's disease: direct correlation of eotaxin expression and tissue eosinophilia.
Blood
93:
2463–2470.
|
|
|
Till KJ,
Lin K,
Zuzel M and
Cawley JC
(2002)
The chemokine receptor CCR7 and alpha4 integrin are important for migration of chronic lymphocytic leukemia cells into lymph nodes.
Blood
99:
2977–2984.
|
|
|
Trentin L,
Cabrelle A,
Facco M et al.
(2004)
Homeostatic chemokines drive migration of malignant B cells in patients with non-Hodgkin lymphomas.
Blood
104:
502–508.
|
|
|
Vallet S,
Raje N,
Ishitsuka K et al.
(2007)
MLN3897, a novel CCR1 inhibitor, impairs osteoclastogenesis and inhibits the interaction of multiple myeloma cells and osteoclasts.
Blood
110:
3744–3752.
|
|
|
Weihrauch MR,
Manzke O,
Beyer M et al.
(2005)
Elevated serum levels of CC thymus and activation-related chemokine (TARC) in primary Hodgkin's disease: potential for a prognostic factor.
Cancer Research
65:
5516–5519.
|
|
|
Zambello R,
Trentin L,
Facco M et al.
(2003)
Upregulation of CXCR1 by proliferating cells in patients with lymphoproliferative disease of granular lymphocytes.
British Journal of Haematology
120:
765–773.
|
|
|
Zannettino AC,
Farrugia AN,
Kortesidis A et al.
(2005)
Elevated serum levels of stromal-derived factor-1alpha are associated with increased osteoclast activity and osteolytic bone disease in multiple myeloma patients.
Cancer Research
65:
1700–1709.
|
| Further Reading |
|
|
Allen SJ,
Crown SE and
Handel TM
(2007)
Chemokine: receptor structure, interactions, and antagonism.
Annual Review of Immunology
25:
787–820.
|
|
|
Ribeiro S and
Horuk R
(2005)
The clinical potential of chemokine receptor antagonists.
Pharmacological Therapy
107:
44–58.
|
|
|
Zlotnik A and
Yoshie O
(2000)
Chemokines: a new classification system and their role in immunity.
Immunity
12:
121–127.
|
